Skip to main content
GILDHealthcare

Gilead Sciences, Inc. (GILD) Insider Trading

In the last 90 days, 5 Gilead Sciences, Inc. (GILD) insiders reported no open-market purchases and 11 sales totaling $15,877,915. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Johanna MercierChief Comm & Corp Aff OfficerSale3,000$156.22$468,660
Oct 15, 2026Andrew D DickinsonChief Financial OfficerSale3,000$156.22$468,660
Oct 1, 2026Daniel Patrick O'DayChairman & CEOSale15,000$147.90$2,218,508
Sep 15, 2026Johanna MercierChief Comm & Corp Aff OfficerSale3,000$144.22$432,646
Sep 15, 2026Andrew D DickinsonChief Financial OfficerSale3,000$145.29$435,870
Sep 1, 2026Daniel Patrick O'DayChairman & CEOSale15,000$148.64$2,229,593
Aug 26, 2026Anthony WeltersCorporate insiderSale18,000$148.62$2,675,219
Aug 20, 2026Jeffrey BluestoneCorporate insiderSale5,000$145.02$725,078
Aug 17, 2026Johanna MercierChief Comm & Corp Aff OfficerSale28,000$137.64$3,853,909
Aug 17, 2026Andrew D DickinsonChief Financial OfficerSale3,000$138.36$415,080

Common questions

GILD insider trading FAQ

Are GILD insiders buying or selling?
Over the last 90 days, GILD insiders were net sellers, reporting $0.00 of open-market purchases and $15,877,915 of sales.
When was the last GILD insider purchase?
No open-market insider purchase of Gilead Sciences, Inc. stock was reported in the last 90 days.
Where does GILD insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Gilead Sciences, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.